Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 22591 AL 22605

The role of quinoline in the development of near-infrared fluorescent probes for diagnosis of Alzheimer's disease

Melo L, Silva AMS, Albuquerque HMT.

Eur J Med Chem. 2025 Oct 15;296:117874. doi: 10.1016/j.ejmech.2025.117874. Epub 2025 Jun 18.

Histone deacetylase 6 inhibitors in Alzheimer's disease therapy: structure design and challenges

Dang B, Chen H, Liu S, Liu H, Kang Z, Yang Z, Yang W, Hu J, Chen X.

Bioorg Med Chem Lett. 2025 Nov 1;127:130318. doi: 10.1016/j.bmcl.2025.130318. Epub 2025 Jun 26.

Therapeutic and clinical potential of thiolutin microneedles on Alzheimer's disease mitigation

Khan GJ, Malik AM.

Int J Pharm. 2025 Sep 15;682:125898. doi: 10.1016/j.ijpharm.2025.125898. Epub 2025 Jun 27.

Oxidative stress - Alzheimer's disease - DNA methylation: the role of arsenic

Antinori D, Lucarelli M, Fuso A.

Essays Biochem. 2025 Nov 26;69(3):201-210. doi: 10.1042/EBC20253019.

An overview of the rivastigmine 13.3 mg/24h transdermal patch as a treatment option for Alzheimer's disease

Fortea J, Ferrer-Picón E.

Expert Rev Neurother. 2025 Sep;25(9):1119-1129. doi: 10.1080/14737175.2025.2527211. Epub 2025 Jul 3.

Lipids modulates Tau and amyloid-β proteins in Alzheimer's disease

Chinnathambi S, Selvakumar S, Chandrashekar M.

Adv Protein Chem Struct Biol. 2025;146:137-159. doi: 10.1016/bs.apcsb.2024.08.005. Epub 2024 Sep 11.

Heat shock proteins regulates Tau protein aggregation in Alzheimer's disease

Chinnathambi S.

Adv Protein Chem Struct Biol. 2025;146:161-178. doi: 10.1016/bs.apcsb.2024.08.003. Epub 2024 Sep 11.

The Interaction between Oligodendrocytes and Aβ in Alzheimer's Disease

Wang W, Huang X, Xu Z, Yu C.

Curr Alzheimer Res. 2025;22(6):403-413. doi: 10.2174/0115672050401966250625171338.

Tauopathies: Emerging discoveries on tau protein, with a special focus on Alzheimer's disease

Hattiholi A, Hegde H, Shetty SK.

Neuropeptides. 2025 Aug;112:102536. doi: 10.1016/j.npep.2025.102536. Epub 2025 Jul 2.

Unravelling the Alzheimer's pathogenesis: Molecular and cellular pathways to neurodegeneration and therapeutic targets

Chauhan P, Wadhwa K, Singh G.

Pathol Res Pract. 2025 Aug;272:156109. doi: 10.1016/j.prp.2025.156109. Epub 2025 Jul 5.

CTAD taskforce: genetic therapies in Alzheimer's disease

Jakabek D, Isaacs AM, De Strooper B, Tuszynski M, Lane R, Uspenskaya O, McDade E, Rafii MS, Mummery CJ.

J Prev Alzheimers Dis. 2025 Sep;12(8):100269. doi: 10.1016/j.tjpad.2025.100269. Epub 2025 Jul 9.

Decoding tau acetylation in Alzheimer's disease and tauopathies: from site-specific mechanisms to therapeutic horizons

Oh YR, Shin MK.

BMB Rep. 2025 Aug;58(8):325-339. doi: 10.5483/BMBRep.2025-0077.

Clinical Role of Brain PET in Alzheimer Disease in the Era of Disease-Modifying Therapies

Franceschi AM, Keir G, Benzinger TLS, Cogswell PM, Ali FZ, Petrella JR, Prescott JW, Whitlow CT, Zaharchuk G, Allen JW; American Society of Functional Neuroradiology (ASFNR).

AJNR Am J Neuroradiol. 2025 Aug 1;46(8):1521-1527. doi: 10.3174/ajnr.A8738.

Deciphering Alzheimer's disease: Molecular mechanisms, preclinical models and strategies to overcome Blood-Brain-Barrier

Bashir DJ, Bhat KA, Bashir M.

Brain Res. 2025 Sep 15;1863:149828. doi: 10.1016/j.brainres.2025.149828. Epub 2025 Jul 9.

Recent Advances in Antibody Therapy for Alzheimer's Disease: Focus on Bispecific Antibodies

Yang HM.

Int J Mol Sci. 2025 Jun 28;26(13):6271. doi: 10.3390/ijms26136271.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias